hexamethonium has been researched along with Emphysema in 2 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
Emphysema: A pathological accumulation of air in tissues or organs.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| SANCETTA, SM | 2 |
2 other studies available for hexamethonium and Emphysema
| Article | Year |
|---|---|
Acute hemodynamic effects of total head-down body tilt and hexamethonium in normal and pulmonary emphysematous subjects.
Topics: Emphysema; Head-Down Tilt; Hemodynamics; Hexamethonium; Hexamethonium Compounds; Posture; Pulmonary | 1957 |
Acute hemodynamic effects of hexamethonium (C6) in patients with emphysematous pulmonary hypertension.
Topics: Emphysema; Hemodynamics; Hexamethonium; Humans; Hypertension; Hypertension, Pulmonary; Muscle Relaxa | 1955 |